Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03338296 |
|
Recruitment Status :
Terminated
(Study was terminated as Eisai agreed to voluntarily withdraw Belviq XR from US market.)
First Posted : November 9, 2017
Last Update Posted : February 12, 2021
|
Sponsor:
Eisai Inc.
Information provided by (Responsible Party):
Eisai Inc.
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | March 30, 2020 |
| Actual Study Completion Date : | April 14, 2020 |
| Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
|---|---|---|
| 1 |
March 30, 2021 |